12 Patents
- US125761482026Engineered Immune Effector Cells for Cancer Immunotherapy That Are Resistant to Fratricide by Virtue of Having Genetically Modified Surface Antigens
Mitenyi Biotec B.V. & Co. Kg
0 cites - US125605402026Method for Single Molecule Localization Microscopy0 cites
- US124983742025Method for Manufacturing a Patient Specific Cell Population Using a Multifunctional Self-contained Apparatus and Tubing Set
MILTENYI BIOTEC B.V. & Co. KG
0 cites - 0 cites
- US123184462025Reducing Side Effects of Immunotherapy Using Genetically Modified Hematopoietic Cells
Miltenyi Biotec B.V. & Co. Kg
0 cites - 0 cites
- US122460652025Immunotherapy of Cancer Patients Using CAR T or CAR NK Cells Combined with Hematopoietic Cells That Have a Modified or Deleted Target Antigen
Miltenyi Biotec B.V. & Co. Kg
0 cites - US119999802024Non-specific Nucleases from the Genus Pseudomonas for Use in Facilitating Flow of Cells Through a Microfluidic Channel
Miltenyi Biotec B.V. & Co. KG
0 cites - US119337872024Devices and Disposables for Patient-specific Cell Therapy Manufacturing
MILTENYI BIOTEC B.V. & Co. KG
0 cites - US118834942024Combination of Immune Effector Cells Specific for a Target Antigen and Hematopoietic Calls That Express the Target Antigen in an Altered Form
MILTENYI BIOTEC B.V. & Co. KG
0 cites - 0 cites
- 0 cites